Copyright Reports & Markets. All rights reserved.

Global Generic Oncology Drugs Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Generic Oncology Drugs Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Large Molecule Drugs
      • 1.4.3 Small Molecule Drugs
    • 1.5 Market by Application
      • 1.5.1 Global Generic Oncology Drugs Market Share by Application (2014-2025)
      • 1.5.2 Hospital Pharmacies
      • 1.5.3 Retail Pharmacies
      • 1.5.4 Online Pharmacies
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Generic Oncology Drugs Market Size
    • 2.2 Generic Oncology Drugs Growth Trends by Regions
      • 2.2.1 Generic Oncology Drugs Market Size by Regions (2014-2025)
      • 2.2.2 Generic Oncology Drugs Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Generic Oncology Drugs Market Size by Manufacturers
      • 3.1.1 Global Generic Oncology Drugs Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Generic Oncology Drugs Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Generic Oncology Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.2 Generic Oncology Drugs Key Players Head office and Area Served
    • 3.3 Key Players Generic Oncology Drugs Product/Solution/Service
    • 3.4 Date of Enter into Generic Oncology Drugs Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Generic Oncology Drugs Market Size by Type (2014-2019)
    • 4.2 Global Generic Oncology Drugs Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Generic Oncology Drugs Market Size (2014-2019)
    • 5.2 Generic Oncology Drugs Key Players in United States
    • 5.3 United States Generic Oncology Drugs Market Size by Type
    • 5.4 United States Generic Oncology Drugs Market Size by Application

    6 Europe

    • 6.1 Europe Generic Oncology Drugs Market Size (2014-2019)
    • 6.2 Generic Oncology Drugs Key Players in Europe
    • 6.3 Europe Generic Oncology Drugs Market Size by Type
    • 6.4 Europe Generic Oncology Drugs Market Size by Application

    7 China

    • 7.1 China Generic Oncology Drugs Market Size (2014-2019)
    • 7.2 Generic Oncology Drugs Key Players in China
    • 7.3 China Generic Oncology Drugs Market Size by Type
    • 7.4 China Generic Oncology Drugs Market Size by Application

    8 Japan

    • 8.1 Japan Generic Oncology Drugs Market Size (2014-2019)
    • 8.2 Generic Oncology Drugs Key Players in Japan
    • 8.3 Japan Generic Oncology Drugs Market Size by Type
    • 8.4 Japan Generic Oncology Drugs Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Generic Oncology Drugs Market Size (2014-2019)
    • 9.2 Generic Oncology Drugs Key Players in Southeast Asia
    • 9.3 Southeast Asia Generic Oncology Drugs Market Size by Type
    • 9.4 Southeast Asia Generic Oncology Drugs Market Size by Application

    10 India

    • 10.1 India Generic Oncology Drugs Market Size (2014-2019)
    • 10.2 Generic Oncology Drugs Key Players in India
    • 10.3 India Generic Oncology Drugs Market Size by Type
    • 10.4 India Generic Oncology Drugs Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Generic Oncology Drugs Market Size (2014-2019)
    • 11.2 Generic Oncology Drugs Key Players in Central & South America
    • 11.3 Central & South America Generic Oncology Drugs Market Size by Type
    • 11.4 Central & South America Generic Oncology Drugs Market Size by Application

    12 International Players Profiles

    • 12.1 Pfizer
      • 12.1.1 Pfizer Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Generic Oncology Drugs Introduction
      • 12.1.4 Pfizer Revenue in Generic Oncology Drugs Business (2014-2019)
      • 12.1.5 Pfizer Recent Development
    • 12.2 GlaxoSmithKline
      • 12.2.1 GlaxoSmithKline Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Generic Oncology Drugs Introduction
      • 12.2.4 GlaxoSmithKline Revenue in Generic Oncology Drugs Business (2014-2019)
      • 12.2.5 GlaxoSmithKline Recent Development
    • 12.3 Novartis
      • 12.3.1 Novartis Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Generic Oncology Drugs Introduction
      • 12.3.4 Novartis Revenue in Generic Oncology Drugs Business (2014-2019)
      • 12.3.5 Novartis Recent Development
    • 12.4 Merck
      • 12.4.1 Merck Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Generic Oncology Drugs Introduction
      • 12.4.4 Merck Revenue in Generic Oncology Drugs Business (2014-2019)
      • 12.4.5 Merck Recent Development
    • 12.5 Celgene
      • 12.5.1 Celgene Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Generic Oncology Drugs Introduction
      • 12.5.4 Celgene Revenue in Generic Oncology Drugs Business (2014-2019)
      • 12.5.5 Celgene Recent Development
    • 12.6 Teva Pharmaceutical
      • 12.6.1 Teva Pharmaceutical Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Generic Oncology Drugs Introduction
      • 12.6.4 Teva Pharmaceutical Revenue in Generic Oncology Drugs Business (2014-2019)
      • 12.6.5 Teva Pharmaceutical Recent Development
    • 12.7 Mylan
      • 12.7.1 Mylan Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Generic Oncology Drugs Introduction
      • 12.7.4 Mylan Revenue in Generic Oncology Drugs Business (2014-2019)
      • 12.7.5 Mylan Recent Development
    • 12.8 Aurobindo Pharma
      • 12.8.1 Aurobindo Pharma Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Generic Oncology Drugs Introduction
      • 12.8.4 Aurobindo Pharma Revenue in Generic Oncology Drugs Business (2014-2019)
      • 12.8.5 Aurobindo Pharma Recent Development
    • 12.9 Hikma Pharmaceuticals
      • 12.9.1 Hikma Pharmaceuticals Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Generic Oncology Drugs Introduction
      • 12.9.4 Hikma Pharmaceuticals Revenue in Generic Oncology Drugs Business (2014-2019)
      • 12.9.5 Hikma Pharmaceuticals Recent Development
    • 12.10 Natco Pharma
      • 12.10.1 Natco Pharma Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Generic Oncology Drugs Introduction
      • 12.10.4 Natco Pharma Revenue in Generic Oncology Drugs Business (2014-2019)
      • 12.10.5 Natco Pharma Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Generic Oncology Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Generic Oncology Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Generic Oncology Drugs development in United States, Europe and China.

      The key players covered in this study
      Pfizer
      GlaxoSmithKline
      Novartis
      Merck
      Celgene
      Teva Pharmaceutical
      Mylan
      Aurobindo Pharma
      Hikma Pharmaceuticals
      Natco Pharma

      Market segment by Type, the product can be split into
      Large Molecule Drugs
      Small Molecule Drugs

      Market segment by Application, split into
      Hospital Pharmacies
      Retail Pharmacies
      Online Pharmacies

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Generic Oncology Drugs status, future forecast, growth opportunity, key market and key players.
      To present the Generic Oncology Drugs development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Generic Oncology Drugs are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now